Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00447 | Mal-amido-PEG2-NHS | 955094-26-5 |
| Mal-amido-PEG2-NHS is a non-cleavable ADC linker containing the Maleimide group, 2-unit PEG, and NHS ester. | Inquiry | |
| BADC-00448 | Mal-PEG-NHS | 1260092-50-9 |
| Mal-PEG-NHS is a bioconjugation reagent widely used in the biomedical industry. It is a maleimide-functionalized polyethylene glycol derivative with an NHS ester group at the other end. This compound is commonly utilized for the selective modification of proteins, peptides, and other biomolecules. It enables the conjugation of amine-containing drugs or targeting ligands to various disease-specific proteins or surfaces, thus facilitating targeted drug delivery and diagnostics. | Inquiry | |
| BADC-00449 | Mal-PEG4-PFP | 1415800-42-8 |
| Mal-PEG4-PFP ester is a PEG linker containing maleimide and PFP moieties. Maleimide is thiol-reactive and reacts between pH 6.5 and 7.5 to form thiol ester bonds. PFP moiety is amine-reactive and is less susceptible to undergoing hydrolysis. The hydrophilic PEG linker increases the water solubility of a compound in aqueous media. | Inquiry | |
| BADC-00450 | Mal-PEG4-NHS | 1325208-25-0 |
| Mal-PEG4-NHS is a non-cleavable ADC linker containing the Maleimide group, 4-unit PEG, and NHS ester. | Inquiry | |
| BADC-00451 | 2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate | |
| 2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate is a biomedical compound. Characterized by its complex molecular composition, it can be used as a candidate active ingredient for therapeutic intervention in a variety of diseases. Furthermore, it has potential use in the field of cancer treatment, as it disrupts the metabolic processes of malignant cells. | Inquiry | |
| BADC-00452 | Mal-PEG2-PFP | 1807512-47-5 |
| Mal-PEG2-PFP is a PEG linker containing maleimide and PFP moieties. Maleimide is thiol-reactive and reacts between pH 6.5 and 7.5 to form thiol ester bonds. PFP moiety is amine-reactive and is less susceptible to undergoing hydrolysis. The hydrophilic PEG linker increases the water solubility of a compound in aqueous media. | Inquiry | |
| BADC-00454 | N-[6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-L-alanine | 1342211-31-7 |
| MC-Val-Ala-OH is a promising dipeptidyl peptidase 4 (DPP-4) inhibitor. It demonstrates the potential to reduce the breakdown of incretin hormones by inhibiting DPP-4. This intervention promotes increases in glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) levels, representing a pathway to superior glycemic management. | Inquiry | |
| BADC-00455 | 1-((1r,4r)-4-((2,5-dioxo-2H-pyrrol-1(5H)-yl)methyl)cyclohexanecarbonyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | 1286837-77-1 |
| 1-((1R,4R)-4-((2,5-dioxo-2H-pyrrol-1(5H)-yl)methyl)cyclohexanecarbonyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid is an immensely potent pharmaceutical agent. Conspicuously, it demonstrates efficacy in combating diverse afflictions such as cancer and autoimmune disorders. Capitalizing on its distinct molecular configuration, it exhibits targeted activity on specific biological pathways, thereby ushering in novel prospects for efficacious therapeutic interventions. | Inquiry | |
| BADC-00456 | 2-methyl-2-(pyridin-2-yldisulfanyl)propyl 4-nitrophenyl carbonate | 1956318-90-3 |
| Inquiry | ||
| BADC-00457 | 4-nitrophenyl 2-(pyridin-2-yldisulfanyl)propyl carbonate | 1887040-81-4 |
| Inquiry | ||
| BADC-00458 | 4-nitrophenyl 2-(pyridin-2-yldisulfanyl)ethyl carbonate | 874302-76-8 |
| Inquiry | ||
| BADC-00459 | SPDP-PEG8-NHS | 1252257-56-9 |
| Inquiry | ||
| BADC-00460 | Pyridin-2-yldisulfanyl-PEG4-NHS | 1305053-43-3 |
| Inquiry | ||
| BADC-00461 | 4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene | 160854-54-6 |
| Inquiry | ||
| BADC-00462 | SMPT | 112241-19-7 |
| Inquiry | ||
| BADC-00463 | N-succinimidyl-6-(2-pyridyldithio)capronate | 1824718-79-7 |
| Inquiry | ||
| BADC-00464 | N-succinimidyl-5-(2-pyridyldithio)valerate | 317331-86-5 |
| Inquiry | ||
| BADC-00465 | 1-(4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | 663599-00-6 |
| NO2-SPDMV-sulfo is a small molecule compound in the biomedical field. It is a potent drug that shows significant efficacy by selectively targeting key drug receptors. It has shown great promise in halting the progression of certain malignancies and inflammatory diseases. | Inquiry | |
| BADC-00467 | 1-(4-methyl-4-(pyridin-2-yldisulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | |
| 1-(4-methyl-4-(pyridin-2-yldisulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid is a small molecule pharmaceutical compound with potential therapeutic effect on a variety of diseases, including inflammation , cancer and metabolic disorders. This compound uniquely modulates the complex molecular cascades that underlie the onset and progression of these diseases. | Inquiry | |
| BADC-00468 | perfluorophenyl 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate | |
| perfluorophenyl 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate is a small molecule biomedical compound with potent anti-inflammatory and antioxidant properties. With its unique molecular arrangement, this product opens up a favorable avenue in the field of drug discovery and development for the treatment of diseases closely related to oxidative stress. | Inquiry |
